product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Erk5 (D23E9) Rabbit mAb
catalog :
3552
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D23E9
reactivity :
human, mouse, rat
application :
western blot
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 6e
Tan P, Ye Y, He L, Xie J, Jing J, Ma G, et al. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10. PLoS Biol. 2018;16:e3000051 pubmed publisher
  • western blot; mouse; fig 3
  • western blot; human; fig s7
de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed publisher
  • western blot; human; 1:1000; fig s1
Qiu Z, Sun R, Mo X, Li W. The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth. PLoS ONE. 2016;11:e0147185 pubmed publisher
  • western blot; human; fig 3
Gavine P, Wang M, Yu D, Hu E, Huang C, Xia J, et al. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma. BMC Cancer. 2015;15:454 pubmed publisher
product information
SKU :
3552S
Product-Name :
Erk5 (D23E9) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
115
Host :
Rabbit
Target :
ERK5
Primary-Protein :
ERK5
Alt-Names :
BMK-1,BMK1,BMK1 kinase,Big MAP kinase 1,ERK-5,ERK4,ERK5,Extracellular signal-regulated kinase 5,MAP kinase 7,MAPK 7,MAPK7,MK07,Mitogen-activated protein kinase 7,PRKM7,extracellular-signal-regulated kinase 5
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.